Free vaccination camp for women held at Andhra Hospitals
The HPV vaccine or Human Papilloma Virus vaccine was administered for free to 70 women aged between 9 and 45 at the hospital. The vaccination programme was funded by actor Mahesh Babu Foundation and the hospital.
While girls aged between 9 and 14 would receive two doses at six month interval, those aged between 15 and 45 would receive three doses in the order of a two-month gap between the first and the second dose and a four-month gap between the second and third dose. Each dose costs ₹2,000.
P.V. Rama Rao, head of Children's Services, and Paturi Padma, chief of Fetal Medicine, said the vaccination camp would be useful for children and women against one of the common cancers seen in women.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
a day ago
- NDTV
Cervical Cancer: Risk Factors & Lifestyle Changes You Can Make Today
Cervical cancer begins in the cervix. The cervix is a narrow opening where the baby grows inside the uterus in a woman's body. It occurs when the cells present in your cervix turn cancerous. HPV (human papillomavirus) infection is the cause behind almost all cervical cancer cases. HPV spreads through sexual contact and getting regular check ups such as Pap smear can help in early detection. You can also receive an HPV vaccine to further lower your risk. Focusing on cervical cancer and its prevention is imperial since it is the 3rd most common cancer in India, with a rate of 18.3% (123,907 cases). It is the also the second leading cause behind death with its mortality rate lying at 9.1% as per GLOBOCAN. Cervical cancer accounts for about 6-29% of all cancers in India in women. This makes it crucial to research upon this cancer, understand your risk factors and understand what lifestyle changes you can make today to reduce your risk. Keep reading as we share a list of risk factors and also share lifestyle changes you can make today to reduce your risk of cervical cancer. What are common risk factors of cervical cancer? There are two types of risk factors, factors you can change such as lifestyle changes or factors that are inherit and can't be changed such as your age, family history, etc. Let's understand these factors: 1. Weak immunity Like many other conditions, poor immunity can jeopardise your health and increase your risk of cervical cancer. You have created changes of developing cervical cancer if you can a weakened immune system or if you have HPV. 2. Smoking Smoking tobacco greatly increases your risk of various kinds of cancers including cervical cancer. If you are a smoker and have contracted HPV, it is more likely to last longer and less likely it will go away similar to other infections. 3. Multiple sexual partners Since the leading cause behind cervical cancer is HPV, you are directly at a higher risk of developing cervical cancer if you have a higher number of sexual partners. It occurs as you are more exposed to contracting this virus in the first place. Also read: 4. Other sexually transmitted diseases Other sexually transmitted diseases such as STIs can further increase your risk of HPV which as discussed can lead to cervical cancer. Some common STIs that can increase your risk include herpes, syphilis, chlamydia, gonorrhoea and HIV/AIDS. 5. Lower socioeconomic background The first step to prevention is education. Women that belong to a lower strata socioeconomically are at a higher risk of developing cervical cancer via HPV or other factors. Since they often lack proper education, have non-availability of proper medication and treatment, or affordable healthcare, they might be at a higher risk. 6. Pregnancy Women who have gone through 3 or more full term pregnancies are at a higher risk of contracting cervical cancer. Women who get pregnant before the age of 20 might also be at a higher risk as compared to women over the age of 25. 7. Early onset of menstrual cycle Women that start their menstrual cycle way before expected (also also menarche) are at a higher risk of developing cervical cancer. This occurs due to the early production of oestrogen in the body which is found to be a contributing factor in increasing risk of cervical cancer. 8. Long-term use of oral birth control Oral contraceptives such as birth control pills might increase your risk of cervical cancer if taken over a long period of time. This factor is supported by some research and stopping the consumption of PCs might reduce your risk in the future. You are encouraged to discuss all risks and side effects of OCs with your doctor to understand whether your needs outweigh the potential risks. Now that you understand factors that might put you at risk, lets' understand what lifestyle changes can help you reduce your risk of cervical cancer. Lifestyle changes you can adopt today to reduce risk of cervical cancer Get pap smears, HPV test and any other tests you can get to ensure early detection. You are advised to get pap smear test every 2-3 years and a HPV test every 5 years after the age of 25. Get vaccinated against the HPV. HPV vaccination is crucial for cervical prevention. Since HPV is an STI and a leading cause of CC, you are encouraged to practice safe sex. Keep an eye for early signs or symptoms of cervical cancer to ensure early treatment. Stop smoking today to reduce your risk of cervical cancer along with other cancers. Exercising regularly reduces risk of CC as it strengthens the immunity and maintains hormonal balance. Follow these lifestyle changes today to ensure better health and to reduce your risk of cervical cancer. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
Time of India
2 days ago
- Time of India
Philippines accelerates TB elimination drive with India's community-based screening devices
New Delhi: The Philippines, one of the top five countries with the highest tuberculosis (TB) burden, faces the challenge of detecting and treating an estimated 1,90,000 missed TB cases each year, an official statement said. In line with the United Nations target to find and treat 2.1 million Tuberculosis cases in the country by 2027, the Philippines' Health Department is stepping up its commitment to strengthen community-level screening and diagnosis through India-made innovative Truenat® systems and ultra-portable X-ray devices. Currently, there are 68 Truenat® devices deployed across the Philippines, enabling rapid, multi-disease molecular testing for TB, HIV, HPV, Hepatitis B & C, and more. A pilot in the Bantayan Islands demonstrated the transformative potential of the platform, achieving a remarkable 1008% increase in TB case detection, as per the statement. Molbio's WHO-endorsed and ICMR-approved solutions for TB detection address critical barriers in the Philippines, such as geographic isolation, underutilization of laboratory testing, and limited access in rural and island communities. The recent approval of the PRORAD Atlas Ultraportable X-ray by the Philippines FDA paves the way for integrated, end-to-end TB screening and diagnosis, ensuring immediate linkage to treatment. Health Secretary of the Philippines Theodore J Herbosa said, "As we intensify our efforts to combat tuberculosis (TB) in the Philippines, the collaboration with India stands as a beacon of innovation and partnership. The integration of India's indigenous diagnostic technologies, such as the Truenat® system, into our healthcare infrastructure is pivotal. Truenat®, known for its rapid and reliable molecular diagnostic capabilities, allows for swift and accurate TB screenings, enhancing our capacity to manage and eventually eliminate TB within our borders, especially in remote areas." "This collaboration is part of a broader strengthening bilateral relationship between India and the Philippines, which now exceeds USD 3 billion in trade. India is a key supplier of pharmaceuticals, medical equipment, and diagnostic technologies, contributing significantly to our healthcare advancements. Our partnership with India is a prime example of how collaboration in health, technology, trade and defence can come together to address pressing challenges and enhance our bilateral ties, driving both healthcare progress and economic prosperity in our nations," added Theodore. As part of its ongoing commitment to the Philippines, Molbio Diagnostics will host a high-impact panel at the 31st Philippine Coalition Against Tuberculosis (PhilCAT) Annual Convention on August 14-15, 2025, in Manila. With a portfolio spanning more than 40 tests for infectious and non-infectious diseases, Molbio combines portability, speed, and accuracy to strengthen public health systems worldwide. Molbio's ongoing studies include a multi-country project funded by the R2D2 TB Network that is exploring novel tongue swab-based molecular diagnostics to improve TB detection among children and people living with HIV/AIDS, the statement said. "By bringing testing closer to communities--whether on remote islands or underserved rural areas--we can close the gap in TB detection and treatment, helping the Philippines achieve its elimination targets. We are committed to strengthening the fight against infectious diseases across the globe, helping countries build more resilient and responsive health systems," said Shiva Sriram, President of Molbio Diagnostics. (ANI)
Time of India
3 days ago
- Time of India
AIIMS-R VRDL gets accreditation for diagnosis of 12 major viral infections
Raipur: The state viral research and diagnostic laboratory (VRDL) at the All India Institute of Medical Sciences (AIIMS), Raipur, has received its first accreditation from National Accreditation Board for Testing & Calibration Laboratories (NABL). The laboratory, which functions under the Department of Microbiology, was accredited for the diagnosis of 12 major viral infections. These include viral meningitis and encephalitis, COVID-19 (SARS-CoV-2), swine flu ( H1N1 ), influenza B, respiratory syncytial virus (RSV), and 14 high-risk human papillomavirus (HR-HPV) types that cause cervical cancer . The list also includes Epstein-Barr virus (EBV), Herpes simplex virus (HSV), cytomegalovirus (CMV), Hepatitis B and C viral load, and dengue. Established in 2018, the VRDL provides diagnostic services to patients at AIIMS Raipur and receives samples from across Chhattisgarh. It is involved in testing for COVID-19, Hepatitis A, B, C, E, and dengue. The lab also assists in investigating outbreaks of viral diseases like chickenpox, conjunctivitis, and mumps. The VRDL is the state nodal centre for COVID-19 testing , quality control, and whole genome sequencing of SARS-CoV-2. Lt Gen Ashok Jindal (Retd), Executive Director and CEO of AIIMS Raipur, congratulated the team for their achievement, stating that the NABL accreditation is a step towards national recognition for the diagnostic services provided to the people of Chhattisgarh. Prof Dr Anudita Bhargava, Head, Department of Microbiology, said the recognition was the result of teamwork and dedication by the entire staff.
